Generali Investments CEE’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$889K Hold
12,700
– – 0.04% 304
2026
Q1
$645K Hold
12,700
– – 0.03% 328
2025
Q4
$375K Hold
12,700
– – 0.03% 325
2025
Q3
$328K Hold
12,700
– – 0.03% 322
2025
Q2
$350K Buy
12,700
+7,400
+140% +$195K 0.03% 306
2025
Q1
$150K Hold
5,300
– – 0.01% 341
2024
Q4
$220K Buy
+5,300
New +$253K 0.02% 302

Other funds holding MRNA

Generali Investments CEE's MRNA Position: Q2 2026 in Review

Generali Investments CEE held its Moderna (MRNA) position steady in Q2 2026 at 12,700 shares worth $889K. The position accounts for 0.04% of the portfolio, ranked #304.

Generali Investments CEE first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Generali Investments CEE held 12,700 shares of Moderna worth $889K as of Q2 2026.
  • Generali Investments CEE left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.04% of Generali Investments CEE's portfolio in Q2 2026, its #304 holding.
  • Generali Investments CEE first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.